Attached files

file filename
EX-4.24 - THIRD AMENDMENT TO 2011 STOCK INCENTIVE PLAN - Avid Bioservices, Inc.peregrine_10k-ex0424.htm
EX-23.1 - CONSENT - Avid Bioservices, Inc.peregrine_10k-ex2301.htm
EX-4.27 - AMENDMENT TO FORM OF STOCK OPTION AWARD AGREEMENT - Avid Bioservices, Inc.peregrine_10k-ex0427.htm
EX-4.22 - FIRST AMENDMENT TO 2005 STOCK INCENTIVE PLAN - Avid Bioservices, Inc.peregrine_10k-ex0422.htm
EX-4.26 - AMENDMENT TO FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT - Avid Bioservices, Inc.peregrine_10k-ex0426.htm
EX-32 - CERTIFICATION - Avid Bioservices, Inc.peregrine_10k-ex32.htm
EX-31.2 - CERTIFICATION - Avid Bioservices, Inc.peregrine_10k-ex3102.htm
EX-31.1 - CERTIFICATION - Avid Bioservices, Inc.peregrine_10k-ex3101.htm
EX-4.25 - AMENDMENT TO FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT - Avid Bioservices, Inc.peregrine_10k-ex0425.htm
10-K - ANNUAL REPORT - Avid Bioservices, Inc.peregrine_10k-043015.htm
EX-4.23 - FIRST AMENDMENT TO 2009 STOCK INCENTIVE PLAN - Avid Bioservices, Inc.peregrine_10k-ex0423.htm

EXHIBIT 21

 

PEREGRINE PHARMACEUTICALS, INC.

Subsidiaries of Registrant

 

On August 28, 2006, we established a wholly-owned subsidiary, Peregrine (Beijing) Pharmaceutical Technology Ltd. in the Haidian District, Beijing, People’s Republic of China.

 

During January 2002, we announced the formation of Avid Bioservices, Inc., a wholly-owned subsidiary of Peregrine Pharmaceuticals, Inc.

 

On April 24, 1997, we acquired our wholly-owned subsidiary, Vascular Targeting Technologies, Inc. (formerly known as Peregrine Pharmaceuticals, Inc.).